Title: Early-onset Alzheimer's disease
Content: extremely rare. The majority of people with early-onset Alzheimer's are in their 50s or early 60s. The symptoms of the disease as a distinct nosologic entity were first identified by Emil Kraepelin, and the characteristic neuropathology was first observed by Alois Alzheimer in 1906. In this sense, the disease was co-discovered by Kraepelin and Alzheimer, who worked in Kraepelin's laboratory. Because of the overwhelming importance Kraepelin attached to finding the neuropathological basis of psychiatric disorders, Kraepelin made the decision that the disease would bear Alzheimer's name. Familial Alzheimer's disease (FAD) or early-onset familial Alzheimer's disease (EOFAD) is an uncommon form

Title: Alzheimer's Association
Content: to form a national organization. The groups consisted of researchers, physicians, caregivers, and other humanitarians. Together they held their first official meeting on December 4, 1979, to discuss solutions for the need for Alzheimer's information, care, and cure for the disease. The Alzheimer's Disease and Related Disorders Association was incorporated on April 10, 1980. In that year, the National Institutes of Health (NIH) invested $13 million in Alzheimer's disease research. In 1982, President Ronald Reagan designated the first National Alzheimer's Disease Awareness Week. With sub-chapters being founded nationwide, the organization launched its own research programs. In 1980 actress and dancer

Title: Michael I. Miller
Content: one of the papers that contributed to a deeper understanding of the disorder in its earlier stages and the recommendations of the working group to revise the diagnostic criteria for Alzheimer’s disease dementia for the first time in 27 years. In 2009, the Johns Hopkins University BIOCARD project was initiated, led by Marilyn Albert, to study preclinical Alzheimer's disease. In 2014, Miller and Younes demonstrated that the original Braak staging of the earliest change associated to the entorhinal cortex in the medial temporal lobe could be demonstrated via diffeomorphometry methods in the population of clinical MRIs, and subsequently that this

Title: Alzheimer's Disease Neuroimaging Initiative
Content: fund a large biomarker project to study AD and to speed up progress toward effective treatments for the disease was conceived at the beginning of the millennium by Neil S. Buckholz at the National Institute on Aging (NIA) and Dr. William Potter, at Eli Lilly and Company. The Alzheimer's Disease Neuroimaging Initiative (ADNI) began in 2004 under the leadership of Dr. Michael W. Weiner, funded as a private – public partnership with $27 million contributed by 20 companies and two foundations through the Foundation for the National Institutes of Health and $40 million from the NIA. The initial five-year study

Title: Alzheimer's disease
Content: the eighth edition of his "Textbook of Psychiatry", published on 1910. For most of the 20th century, the diagnosis of Alzheimer's disease was reserved for individuals between the ages of 45 and 65 who developed symptoms of dementia. The terminology changed after 1977 when a conference on AD concluded that the clinical and pathological manifestations of presenile and senile dementia were almost identical, although the authors also added that this did not rule out the possibility that they had different causes. This eventually led to the diagnosis of "Alzheimer's disease" independent of age. The term "senile dementia of the Alzheimer

Question: In which decade was Alzheimer's disease first clinically described?
Answer: First decade